Publications by authors named "Lucia Carolina Pena"
Article Synopsis
- Recombinant human interferon alpha (rhIFN-α2b) has been a long-time treatment for viral diseases but has issues like immunogenicity and a short half-life.
- Two new hyperglycosylated proteins, 4N-IFN(VAR1) and 4N-IFN(VAR3), have been developed to address these limitations, showing lower immune responses compared to the original.
- Studies indicate these new proteins are more stable under various production and storage conditions, making them promising candidates for treating viral diseases in humans.
